Published in Proc Am Thorac Soc on April 15, 2008
Prostaglandin E(2) induces fibroblast apoptosis by modulating multiple survival pathways. FASEB J (2009) 1.41
Does chronic microaspiration cause idiopathic pulmonary fibrosis? Am J Med (2010) 1.30
Regulatory T cells reduce acute lung injury fibroproliferation by decreasing fibrocyte recruitment. Am J Respir Cell Mol Biol (2012) 1.28
Interstitial lung diseases in children. Orphanet J Rare Dis (2010) 1.28
Pleural mesothelial cell transformation into myofibroblasts and haptotactic migration in response to TGF-beta1 in vitro. Am J Physiol Lung Cell Mol Physiol (2009) 1.27
TLR9 differentiates rapidly from slowly progressing forms of idiopathic pulmonary fibrosis. Sci Transl Med (2010) 1.21
Endothelin-1 and transforming growth factor-beta1 independently induce fibroblast resistance to apoptosis via AKT activation. Am J Respir Cell Mol Biol (2009) 1.20
Mesenchymal cell survival in airway and interstitial pulmonary fibrosis. Fibrogenesis Tissue Repair (2010) 1.17
Bone marrow stem cells expressing keratinocyte growth factor via an inducible lentivirus protects against bleomycin-induced pulmonary fibrosis. PLoS One (2009) 1.15
Viruses as co-factors for the initiation or exacerbation of lung fibrosis. Fibrogenesis Tissue Repair (2008) 1.13
Signaling pathways in the epithelial origins of pulmonary fibrosis. Cell Cycle (2010) 1.10
Increased survivin expression contributes to apoptosis-resistance in IPF fibroblasts. Adv Biosci Biotechnol (2012) 0.98
The lens as a model for fibrotic disease. Philos Trans R Soc Lond B Biol Sci (2011) 0.97
Lung fibrotic tenascin-C upregulation is associated with other extracellular matrix proteins and induced by TGFβ1. BMC Pulm Med (2014) 0.85
Mechanobiology in lung epithelial cells: measurements, perturbations, and responses. Compr Physiol (2012) 0.80
Validated prediction of pro-invasive growth factors using a transcriptome-wide invasion signature derived from a complex 3D invasion assay. Sci Rep (2015) 0.77
Lipoxin A4 promotes lung epithelial repair whilst inhibiting fibroblast proliferation. ERJ Open Res (2016) 0.75
Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature (1992) 16.46
The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell (1999) 11.59
Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med (2001) 8.95
Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc Natl Acad Sci U S A (2006) 7.08
A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. N Engl J Med (2004) 6.02
Bone marrow-derived progenitor cells in pulmonary fibrosis. J Clin Invest (2004) 5.97
A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. N Engl J Med (1999) 4.83
Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am J Pathol (2001) 4.39
Mechanisms of pulmonary fibrosis. Annu Rev Med (2004) 4.37
Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans. Proc Natl Acad Sci U S A (2002) 4.00
Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis. Proc Natl Acad Sci U S A (2000) 3.47
Common promoter variant in cyclooxygenase-2 represses gene expression: evidence of role in acute-phase inflammatory response. Arterioscler Thromb Vasc Biol (2002) 2.84
The role of CCL12 in the recruitment of fibrocytes and lung fibrosis. Am J Respir Cell Mol Biol (2006) 2.68
Mortality from pulmonary fibrosis increased in the United States from 1992 to 2003. Am J Respir Crit Care Med (2007) 2.66
Cultured lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis have a diminished capacity to synthesize prostaglandin E2 and to express cyclooxygenase-2. J Clin Invest (1995) 2.59
Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease. Biochem Biophys Res Commun (2006) 2.52
Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome. Am J Respir Crit Care Med (2002) 2.51
Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms? Eur Respir J (2007) 2.47
Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis. J Clin Invest (1999) 2.43
Ligation of protease-activated receptor 1 enhances alpha(v)beta6 integrin-dependent TGF-beta activation and promotes acute lung injury. J Clin Invest (2006) 2.40
Activation of a signaling cascade by cytoskeleton stretch. Dev Cell (2004) 2.35
Global expression profiling of fibroblast responses to transforming growth factor-beta1 reveals the induction of inhibitor of differentiation-1 and provides evidence of smooth muscle cell phenotypic switching. Am J Pathol (2003) 2.14
Fibroblasts and myofibroblasts: their source, function and role in disease. Int J Biochem Cell Biol (2006) 2.02
Evolving concepts of apoptosis in idiopathic pulmonary fibrosis. Proc Am Thorac Soc (2006) 1.98
Cyclooxygenase-2 deficiency results in a loss of the anti-proliferative response to transforming growth factor-beta in human fibrotic lung fibroblasts and promotes bleomycin-induced pulmonary fibrosis in mice. Am J Pathol (2001) 1.96
Abrogation of bleomycin-induced epithelial apoptosis and lung fibrosis by captopril or by a caspase inhibitor. Am J Physiol Lung Cell Mol Physiol (2000) 1.86
Alveolar epithelial cell death adjacent to underlying myofibroblasts in advanced fibrotic human lung. Am J Physiol (1998) 1.81
Transforming growth factors-beta 1, -beta 2, and -beta 3 stimulate fibroblast procollagen production in vitro but are differentially expressed during bleomycin-induced lung fibrosis. Am J Pathol (1997) 1.70
Pulmonary fibrosis: cytokines in the balance. Eur Respir J (1998) 1.64
Severity of lung injury in cyclooxygenase-2-deficient mice is dependent on reduced prostaglandin E(2) production. Am J Pathol (2004) 1.56
Absence of proteinase-activated receptor-1 signaling affords protection from bleomycin-induced lung inflammation and fibrosis. Am J Pathol (2005) 1.53
A new direction in the pathogenesis of idiopathic pulmonary fibrosis? Respir Res (2001) 1.47
Clinical relevance of airway remodelling in airway diseases. Eur Respir J (2007) 1.44
Angiotensin II is mitogenic for human lung fibroblasts via activation of the type 1 receptor. Am J Respir Crit Care Med (2000) 1.44
Dynamic state of collagen: pathways of collagen degradation in vivo and their possible role in regulation of collagen mass. Am J Physiol (1987) 1.42
Thrombin is a potent inducer of connective tissue growth factor production via proteolytic activation of protease-activated receptor-1. J Biol Chem (2000) 1.41
Science review: role of coagulation protease cascades in sepsis. Crit Care (2002) 1.37
Direct thrombin inhibition reduces lung collagen, accumulation, and connective tissue growth factor mRNA levels in bleomycin-induced pulmonary fibrosis. Am J Pathol (2001) 1.31
Transgenic modeling of transforming growth factor-beta(1): role of apoptosis in fibrosis and alveolar remodeling. Proc Am Thorac Soc (2006) 1.31
The acute respiratory distress syndrome: fibrosis in the fast lane. Thorax (1998) 1.29
Proteases and lung injury. Crit Care Med (2003) 1.27
Inverse effects of interleukin-6 on apoptosis of fibroblasts from pulmonary fibrosis and normal lungs. Am J Respir Cell Mol Biol (2003) 1.27
TGF-beta: its role in asthma and therapeutic potential. Curr Drug Targets (2006) 1.27
Thrombin stimulates fibroblast procollagen production via proteolytic activation of protease-activated receptor 1. Biochem J (1998) 1.23
Indomethacin suppresses the anti-proliferative effects of transforming growth factor-beta isoforms on fibroblast cell cultures. Biochem J (1997) 1.19
Mice lacking neutrophil elastase are resistant to bleomycin-induced pulmonary fibrosis. Am J Pathol (2007) 1.13
Chronic effects of mechanical force on airways. Annu Rev Physiol (2006) 1.11
Mechanical signals regulating extracellular matrix gene expression in fibroblasts. Scand J Med Sci Sports (2005) 1.09
Endothelin-1 and endothelin-3 induce chemotaxis and replication of pulmonary artery fibroblasts. Am J Respir Cell Mol Biol (1992) 1.04
Administration of truncated secretory leukoprotease inhibitor ameliorates bleomycin-induced pulmonary fibrosis in hamsters. Am J Respir Crit Care Med (1996) 1.03
Effects of neutrophil elastase inhibitor on bleomycin-induced pulmonary fibrosis in mice. Am J Respir Crit Care Med (1997) 1.03
The effect of transforming growth factor beta on rates of procollagen synthesis and degradation in vitro. Biochim Biophys Acta (1991) 1.02
Regulation of fibroblast procollagen production. Transforming growth factor-beta 1 induces prostaglandin E2 but not procollagen synthesis via a pertussis toxin-sensitive G-protein. Biochem J (1995) 1.00
Factor Xa stimulates fibroblast procollagen production, proliferation, and calcium signaling via PAR1 activation. Exp Cell Res (2004) 0.99
Administration of alpha 1-proteinase inhibitor ameliorates bleomycin-induced pulmonary fibrosis in hamsters. Am Rev Respir Dis (1992) 0.95
Mechanotransduction determines the structure and function of lung and bone: a theoretical model for the pathophysiology of chronic disease. Cell Biochem Biophys (2003) 0.92
Regulation of connective tissue homeostasis in the skin by mechanical forces. Clin Exp Rheumatol (2004) 0.91
Anticytokine approaches in pulmonary fibrosis: bringing factors into focus. Thorax (1997) 0.89
Possible roles for apoptosis and apoptotic cell recognition in inflammation and fibrosis. Am J Respir Cell Mol Biol (2003) 0.87
Functional prostaglandin-endoperoxide synthase 2 polymorphism predicts poor outcome in sarcoidosis. Am J Respir Crit Care Med (2006) 0.87
Protein turnover during skeletal muscle hypertrophy. Fed Proc (1980) 0.84
Invited lecture: activation of the epithelial mesenchymal trophic unit in the pathogenesis of asthma. Int Arch Allergy Immunol (2001) 0.83
An integrin-targeted non-viral vector for pulmonary gene therapy. Gene Ther (2000) 0.81
From clot to collagen: coagulation peptides in interstitial lung disease. Eur Respir J (1998) 0.78
Common promoter variant in cyclooxygenase-2 represses gene expression: evidence of role in acute-phase inflammatory response. Arterioscler Thromb Vasc Biol (2002) 2.84
Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome. Am J Respir Crit Care Med (2002) 2.51
Diminished prostaglandin E2 contributes to the apoptosis paradox in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2010) 1.97
Sleep disorders in Parkinson's disease: the contribution of the MPTP non-human primate model. Exp Neurol (2009) 1.70
Severity of lung injury in cyclooxygenase-2-deficient mice is dependent on reduced prostaglandin E(2) production. Am J Pathol (2004) 1.56
Lysophosphatidic acid induces alphavbeta6 integrin-mediated TGF-beta activation via the LPA2 receptor and the small G protein G alpha(q). Am J Pathol (2009) 1.50
The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 1- blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol (2007) 1.49
Angiotensin II and the fibroproliferative response to acute lung injury. Am J Physiol Lung Cell Mol Physiol (2003) 1.46
Can we identify a CT-based tissue window for thrombolysis without CTP? Ann Neurol (2006) 1.40
Factors influencing the detection of early CT signs of cerebral ischemia: an internet-based, international multiobserver study. Stroke (2007) 1.34
Fibroblasts isolated from normal lungs and those with idiopathic pulmonary fibrosis differ in interleukin-6/gp130-mediated cell signaling and proliferation. Am J Pathol (2003) 1.31
Inverse effects of interleukin-6 on apoptosis of fibroblasts from pulmonary fibrosis and normal lungs. Am J Respir Cell Mol Biol (2003) 1.27
TGF-beta: its role in asthma and therapeutic potential. Curr Drug Targets (2006) 1.27
Vitamin D and risk of death from vascular and non-vascular causes in the Whitehall study and meta-analyses of 12,000 deaths. Eur Heart J (2012) 1.20
The role of oxytocin in psychiatric disorders: a review of biological and therapeutic research findings. Harv Rev Psychiatry (2014) 1.18
Pilot study on the effect of grounding on delayed-onset muscle soreness. J Altern Complement Med (2010) 1.11
The Intracerebral Hemorrhage Acutely Decreasing Arterial Pressure Trial. Stroke (2013) 1.10
Tgf-Beta isoform specific regulation of airway inflammation and remodelling in a murine model of asthma. PLoS One (2010) 1.07
Genetic partitioning of interleukin-6 signalling in mice dissociates Stat3 from Smad3-mediated lung fibrosis. EMBO Mol Med (2012) 1.07
Pulmonary epithelium is a prominent source of proteinase-activated receptor-1-inducible CCL2 in pulmonary fibrosis. Am J Respir Crit Care Med (2008) 1.06
A role for endocannabinoids in the generation of parkinsonism and levodopa-induced dyskinesia in MPTP-lesioned non-human primate models of Parkinson's disease. FASEB J (2005) 1.02
A large web-based observer reliability study of early ischaemic signs on computed tomography. The Acute Cerebral CT Evaluation of Stroke Study (ACCESS). PLoS One (2010) 0.97
Oncostatin M stimulates proliferation, induces collagen production and inhibits apoptosis of human lung fibroblasts. Br J Pharmacol (2002) 0.96
Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans. Proc Natl Acad Sci U S A (2012) 0.95
Clinicians and the governance of hospitals: a cross-cultural perspective on relations between profession and management. Soc Sci Med (2006) 0.95
STAT3-mediated signaling dysregulates lung fibroblast-myofibroblast activation and differentiation in UIP/IPF. Am J Pathol (2012) 0.94
S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent. II. A neurochemical, electrophysiological and behavioral characterization in vivo. J Pharmacol Exp Ther (2007) 0.94
Stimulation of cannabinoid receptors reduces levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate model of Parkinson's disease. Mov Disord (2002) 0.93
Reconstruction of massive localised lymphoedema of the scrotum with a novel fasciocutaneous flap: A rare case presentation and a review of the literature. J Plast Reconstr Aesthet Surg (2012) 0.93
Role of Reactive Oxygen Species in Tumor Necrosis Factor-alpha Induced Endothelial Dysfunction. Curr Hypertens Rev (2008) 0.93
A receptor-targeted nanocomplex vector system optimized for respiratory gene transfer. Mol Ther (2008) 0.93
Secretion of apolipoprotein E from macrophages occurs via a protein kinase A and calcium-dependent pathway along the microtubule network. Circ Res (2007) 0.92
The influence of orphan care and other household shocks on health status over time: a longitudinal study of children's caregivers in rural Malawi. AIDS Care (2011) 0.91
S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: II. Actions in rodent, primate, and cellular models of antiparkinsonian activity in comparison to ropinirole. J Pharmacol Exp Ther (2004) 0.90
Fipamezole (JP-1730) is a potent alpha2 adrenergic receptor antagonist that reduces levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson's disease. Mov Disord (2003) 0.90
Evaluation of a porcine model for pulmonary gene transfer using a novel synthetic vector. J Gene Med (2002) 0.90
Childhood maltreatment, emotional dysregulation, and psychiatric comorbidities. Harv Rev Psychiatry (2014) 0.87
Formation of dinuclear titanium and zirconium complexes by olefin metathesis--catalytic preparation of organometallic catalyst systems. Chemistry (2003) 0.87
Quantification of collagen and proteoglycan deposition in a murine model of airway remodelling. Respir Res (2005) 0.87
Dopamine transporter binding is unaffected by L-DOPA administration in normal and MPTP-treated monkeys. PLoS One (2010) 0.87
Functional prostaglandin-endoperoxide synthase 2 polymorphism predicts poor outcome in sarcoidosis. Am J Respir Crit Care Med (2006) 0.87
Clinical outcomes associated with chronic antimicrobial suppression therapy in patients with continuous-flow left ventricular assist devices. Artif Organs (2014) 0.87
Evaluating the burden of amblyopia treatment from the parent and child's perspective. J AAPOS (2010) 0.86
The dopamine D3 receptor antagonist, S33138, counters cognitive impairment in a range of rodent and primate procedures. Int J Neuropsychopharmacol (2010) 0.85
Rotigotine treatment partially protects from MPTP toxicity in a progressive macaque model of Parkinson's disease. Exp Neurol (2006) 0.85
Efficient transfection of non-proliferating human airway epithelial cells with a synthetic vector system. J Gene Med (2004) 0.84
Nebulisation of receptor-targeted nanocomplexes for gene delivery to the airway epithelium. PLoS One (2011) 0.84
Analysis and optimization of the cationic lipid component of a lipid/peptide vector formulation for enhanced transfection in vitro and in vivo. J Liposome Res (2006) 0.81
Airway deposition of nebulized gene delivery nanocomplexes monitored by radioimaging agents. Am J Respir Cell Mol Biol (2013) 0.81
Protein tyrosine kinase signaling is necessary for NO donor-induced late preconditioning against myocardial stunning. Am J Physiol Heart Circ Physiol (2002) 0.81
Delivering care out of the box: the evolution of an HIV harm reduction medical program. J Health Care Poor Underserved (2008) 0.81
The Respecting the Circle of Life trial for American Indian adolescents: rationale, design, methods, and baseline characteristics. AIDS Care (2015) 0.80
Neuroprotective effects of rotigotine in the acute MPTP-lesioned mouse model of Parkinson's disease. Neurosci Lett (2007) 0.79
The impact of radiation on surgical outcomes of immediate breast reconstruction. Am Surg (2011) 0.79
The emergency room diagnosis of gastrointestinal tract perforation: the role of CT. Emerg Radiol (2014) 0.79
Preoperative liver reduction utilizing a novel nutritional supplement. J Laparoendosc Adv Surg Tech A (2011) 0.78
Prescription of medroxyprogesterone acetate to a patient with pedophilia, resulting in Cushing's syndrome and adrenal insufficiency. Sex Abuse (2006) 0.77
The use of infrared aided photography in identification of sites of bruises after evidence of the bruise is absent to the naked eye. J Forensic Leg Med (2010) 0.76
Richard Lower (1631-1691): acknowledging his notable contributions to the exploration of the nervous system. Historical vignette. J Neurosurg (2009) 0.75
Biophysical characterization of an integrin-targeted non-viral vector. Med Sci Monit (2003) 0.75
A scalable, micropore, platelet rich plasma separation device. Biomed Microdevices (2012) 0.75
Nurses' accountability for stroke quality of care: part one: Review of the literature on nursing-sensitive patient outcomes. Can J Neurosci Nurs (2011) 0.75
Quantitative assessment of subepithelial collagen deposition in the airways of mice following ovalbumin sensitization and intratracheal challenge. Chest (2003) 0.75
Public policy and private provisions: changes in residential care from 1991 to 2001. Health Soc Care Community (2006) 0.75
TimeSpan: Using Visualization to Explore Temporal Multi-dimensional Data of Stroke Patients. IEEE Trans Vis Comput Graph (2015) 0.75